Printer Friendly

DR. KRISZTINA ZSEBO JOINS CELL GENESYS AS DIRECTOR OF RESEARCH FOR CELLULAR THERAPY

 DR. KRISZTINA ZSEBO JOINS CELL GENESYS AS
 DIRECTOR OF RESEARCH FOR CELLULAR THERAPY
 FOSTER CITY, Calif., Sept. 8 /PRNewswire/ -- Krisztina M. Zsebo, Ph.D., has joined Cell Genesys Inc. as director of research for cellular therapy. She will be responsible for the company's universal cell transplant program and other product development activities.
 Dr. Zsebo was with Amgen Inc. for the past eight years, most recently as a research scientist and associate director of product development for hematopoietic stem cell factor, a blood cell growth promoting protein which she and her scientific team isolated and characterized and which recently entered clinical trials.
 "Dr. Zsebo is an internationally recognized research scientist with extensive biotechnology industry experience who represents an important addition to the scientific staff at Cell Genesys," said Stephen A. Sherwin, M.D., president and chief executive officer. "Her impressive track record at a very successful biotechnology company demonstrates her commitment to advancing basic scientific discoveries from the laboratory to the clinic.
 "We are pleased that Dr. Zsebo has joined the scientific management team at Cell Genesys -- one with more than 30 years of combined experience at successful biotechnology companies," Dr. Sherwin said. "Her unique skills will be of great value to the product development efforts based on our novel gene targeting technology."
 Prior to her recent work as a product development manager for the stem cell growth factor program at Amgen, Zsebo was a research scientist on the team that brought granulocyte colony-stimulating factor into clinical trials. She joined Amgen in Thousand Oaks, Calif., in 1984, early in the company's history and before its product development activities had progressed into clinical trials.
 Dr. Zsebo holds a doctorate in biochemistry from the University of California at Berkeley. She earned a master's in biochemistry from Oregon State University and a bachelor's degree from the University of Maryland. Dr. Zsebo is an author on more than 50 published scientific papers.
 Cell Genesys Inc. is a privately held biotechnology company which is a pioneer in the application of gene targeting technology to the development of human therapeutic health care products. The company is using gene targeting and related technologies to develop universal cell transplant products, human therapeutic protein products, and human monoclonal antibody products.
 -0- 9/8/92
 /CONTACT: Stephen A. Sherwin, M.D., President and CEO of Cell Genesys, 415-358-9600, x 240/ CO: Cell Genesys ST: California IN: MTC SU: PER


KF-RM -- SF003 -- 7020 09/08/92 12:49 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 8, 1992
Words:407
Previous Article:WOMEN'S MEDICAL CENTER GIVES RUSSIAN WOMEN NEW CHOICES EXPERTS EXPLAIN U.S.-REPRODUCTIVE CARE PRACTICES
Next Article:RIEDEL ENVIRONMENTAL ANTICIPATES CLEANUP CONTRACT AWARD
Topics:


Related Articles
CELL GENESYS ANNOUNCES KEY PRODUCT DEVELOPMENT HIRES
DANIEL HOTH, M.D., FORMER NIH OFFICIAL, JOINS CELL GENESYS
CELL GENESYS PROMOTES KRISZTINA ZSEBO, PH.D., TO VICE PRESIDENT OF PRODUCT DEVELOPMENT
CELL GENESYS ADDS TWO KEY PRODUCT DEVELOPMENT DIRECTORS
CELL GENESYS NAMES EXECUTIVE TEAM FOR NEW SUBSIDIARY, ABGENIX
CELL GENESYS ANNOUNCES EXECUTIVE PROMOTIONS
CELL GENESYS REPORTS SECOND QUARTER RESULTS
JAMES GOWER JOINS CELL GENESYS BOARD OF DIRECTORS
Dr. John Lipani Joins the Abgenix Management Team

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters